Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
Fresenius Kabi
Fresenius Kabi
Medical University of Bialystok
Midwestern Regional Medical Center
Medical Center Alkmaar
French Innovative Leukemia Organisation
University Hospitals, Leicester
Insel Gruppe AG, University Hospital Bern
Kocaeli University
Sir Run Run Shaw Hospital
Ege University
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
Jagiellonian University